Evolus

Evolus is a medical aesthetics company focused on providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures.

Evolus’ primary market is self-pay healthcare. Our lead product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.